EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 273 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,000 | -30.8% | 185 | -13.1% | 0.00% | 0.0% |
| Q4 2018 | $13,000 | +44.4% | 213 | +52.1% | 0.00% | 0.0% |
| Q3 2018 | $9,000 | -87.0% | 140 | -91.8% | 0.00% | -83.3% |
| Q3 2017 | $69,000 | +27.8% | 1,700 | +6.2% | 0.01% | +20.0% |
| Q2 2017 | $54,000 | -79.8% | 1,600 | -82.6% | 0.01% | -80.8% |
| Q1 2017 | $267,000 | -29.2% | 9,183 | -20.0% | 0.03% | -43.5% |
| Q4 2016 | $377,000 | +61.8% | 11,481 | +55.3% | 0.05% | +91.7% |
| Q3 2016 | $233,000 | +80.6% | 7,393 | +61.6% | 0.02% | +33.3% |
| Q2 2016 | $129,000 | -32.8% | 4,576 | -13.2% | 0.02% | -33.3% |
| Q1 2016 | $192,000 | +163.0% | 5,274 | +137.1% | 0.03% | +170.0% |
| Q2 2015 | $73,000 | +78.0% | 2,224 | +48.3% | 0.01% | +66.7% |
| Q4 2014 | $41,000 | -70.9% | 1,500 | -77.3% | 0.01% | -70.0% |
| Q3 2014 | $141,000 | +2.9% | 6,600 | +8.2% | 0.02% | +11.1% |
| Q2 2014 | $137,000 | +953.8% | 6,100 | +1120.0% | 0.02% | +800.0% |
| Q1 2014 | $13,000 | +116.7% | 500 | +47.1% | 0.00% | +100.0% |
| Q3 2013 | $6,000 | – | 340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |